Regulatory
AHPA supports USDA’s proposal to allow pullulan in products labeled organic
August 13th 2020AHPA supports the addition of pullulan to the National List at 7 CFR § 205.605 as a nonagricultural (nonorganic) ingredient that can be used only in tablets and capsules for dietary supplements labeled, “Made with organic (specified ingredients or food group(s)).”
FDA issues warning letters to sellers of supplements marketed as hangover cures
August 6th 2020FDA issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate, or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act.
House Committee approves fiscal bill, includes FDA budget for CBD enforcement
July 15th 2020The bill provides a funding increase of $5 million to protect the public from cannabis-derived products that are in violation of the Federal Food, Drug, and Cosmetic Act, as well as to create a potential regulatory pathway for cannabis-derived products.
New BAPP bulletin summarizes info on adulteration of English lavender oil
July 9th 2020Although the safety and efficacy of authentic English lavender oil have been documented in published clinical trials, due to the comparatively high cost of English lavender essential oil, substitution with other, lower-cost species of Lavandula has been reported.
Artemis International doubles down on exposing adulteration of elderberry extracts
July 6th 2020Artemis International is strengthening its partnership with the American Botanical Council’s Botanical Adulterants Prevention Program and botanical testing specialist Alkemist Labs to investigate suspicions that adulterated elderberry ingredients are infiltrating the U.S. market.
ESHA Research employs new software for label compliance on cannabis edibles
June 19th 2020To help manufacturers of cannabis edibles with recipe formulation, ESHA Research introduced the Genesis R&D Cannabis Labeling module, a comprehensive software solution that offers Oregan Liquor Control Commission (OLCC)-compliant Nutrition Facts label templates, nutrient fields for tracking THC and CBD, and regulatory-compliant product labeling that lists the required packaging elements.
CCSS urges stakeholders to accelerate CBD research, and FDA to develop regulatory pathway
June 16th 2020The Collaborative for CBD Science and Safety is calling on industry, researchers, academia, healthcare practitioners, and regulators to accelerate research and the development of an appropriate federal regulatory framework for cannabidiol (CBD) and CBD-containing products.
Making immune health claims in the time of COVID-19? Be careful.
June 3rd 2020During a May 29 Nutritional Outlook webcast titled “COVID-19 and Immune Health Claims: What Not to Say (Do’s and Don’ts),” attorneys discussed the minefield of making immune health claims against the backdrop of the COVID-19 pandemic.
CRN, CHPA, and UNPA has submitted to FDA a proposed framework for the NDI master file
May 21st 2020In a joint letter to FDA, the industry trade groups propose a framework for FDA to implement a New Dietary Ingredient (NDI) master file and urge clarification on the agency’s views in a final NDI guidance.
BetaVia Complete receives positive novel food opinion from EFSA
May 20th 2020BetaVia Complete, an algae-sourced beta-glucan ingredient from Kemin Industries (Des Moines, IA) has received a positive safety assessment from the European Food Safety Authority for its use as a novel food pursuant to Regulation (EU) 2015/2283.